Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders

Journal of Genetic Counseling

Volumn 16, Issue 5, 2007, Pages 593-606

  McConkie Rosell, Allyn ^a   Abrams, Liane ^b   Finucane, Brenda ^c   Cronister, Amy ^d   Gane, Louise W ^e   Coffey, Sarah M ^e   Sherman, Stephanie ^f   Nelson, Lawrence M ^g   Berry Kravis, Elizabeth ^h   Hessl, David ⁱ   Chiu, Sufen ⁱ   Street, Natalie ^j   Vatave, Ajay ^j   Hagerman, Randi J ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b National Fragile X Foundation   (United States)

^c Elwyn   (United States)

^d GENZYME GENETICS   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^h RUSH UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

more..

Author keywords

Autism spectrum disorders; FMR1; Fragile X syndrome; Fragile X associated tremor ataxia syndrome; Genetic counseling; Newborn screening; Population screening; Premature ovarian failure

Indexed keywords

ADULT; ARTICLE; ATAXIA; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; FRAGILE X MENTAL RETARDATION 1 GENE; FRAGILE X SYNDROME; GENE; GENE MUTATION; GENETIC COUNSELING; HUMAN; INFORMATION PROCESSING; MALE; MEDICAL RESEARCH; PHENOTYPE; TREMOR; UNITED STATES;

FOCUS GROUPS; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MEDICAL HISTORY TAKING; MUTATION;

EID: 36448984927     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-007-9099-y     Document Type: Article

References (64)

1. Anido, A., Carlson, L. M., & Sherman, S. L. (2007). Attitudes toward fragile X mutation carrier testing from women identified in a general population survey. Journal of Genetic Counseling, 16(1), 97-104.
2. Anido, A., Carlson, L. M., Taft, L., & Sherman, S. L. (2005). Women's attitudes toward testing for fragile X carrier status: A qualitative analysis. Journal of Genetic Counseling, 14(4), 295-306.
3. Aziz, M., Stathopulu, E., Callias, M., Taylor, C., Turk, J., Oostra B., et al. (2003). Clinical features of boys with fragile X premutations and intermediate alleles. American Journal of Medical Genetics, 121B(1), 119-127.
4. Bacalman, S., Farzin F., Bourgeois, J., Cogswell, J., Goodlin-Jones, B.,Gane, L. W., et al. (2006). Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: Newly described fronto-subcortical dementia. Journal of Clinical Psychiatry, 67(1), 87-94.
5. Berry-Kravis, E., Potanos, K., Weinberg, D., Zhou, L. L., & Goetz, C. G. (2005). Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation. Annals of Neurology, 57(1), 144-147.
6. Brunberg, J. A., Jacquemont, S., Hagerman R. J., Berry-Kravis, E., Grigsby, J., Leehey, M., et al. (2002). Fragile X premutation carriers: Characteristic MR imaging findings in adult males with progressive cerebellar and cognitive dysfunction. American Journal of Neuroradiology, 23(10), 1757-1766.
7. Chiu, S., Hessl, D., Day, J., et al. (2007). Genetic correlates of psychiatric comorbidity in fragile X syndrome. In M. Bax (Ed.), Comorbidities in genetic syndromes. London: MacKeith (in press).
8. Cornish, K. M., Kogan, C., Turk, J., Manly, T., James, N., & Dalton, A. (2005). The emerging fragile X premutation phenotype: Evidence from the domain of social cognition. Brain and Cognition, 57(1), 53-60.
9. Crawford, D. C., Meadows, K. L., Newman, J. L., Taft, L. F., Scott, E., Leslie, M., et al. (2002). Prevalence of the fragile X syndrome in African-Americans. American Journal of Medical Genetics, 110(3), 226-233.
10. de Vries, B. B., Wiegers, A. M., Smits, A. P., Mohkamsing, S., Duivenvoorden, H. J., Fryns, J. P., et al. (1996). Mental status of females with an FMR1 gene full mutation. American Journal of Medical Genetics, 58(5), 1025-1032.
11. Dombrowski, C., Levesque, S., Morel, M. L., Rouillard, P., Morgan, K., & Rousseau, F. (2002). Premutation and intermediate-size FMR1 alleles in 10 572 males from the general population: Loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Human Molecular Genetics, 11(4), 371-378.
12. Fanos, J. H., Spangner, K. A., & Musci, T. J. (2006). Attitudes toward prenatal screening and testing for Fragile X. Genetics in Medicine, 8(2), 129-133.
13. Farzin, F., Perry, H., Hessl, D., Loesch, D., Cohen, J., Bacalman, S., et al. (2006). Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. Journal of Developmental and Behavioral Pediatrics, 27(2 Suppl), S137-S144.
14. Franke, P., Leboyer, M., Gansicke, M., Weiffenbach, O., Biancalana, V., Cornillet-Lefebre, P., et al. (1998). Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Research, 80(2), 113-127.
15. Freund, L. S., Reiss, A. L., & Abrams, M. T. (1993). Psychiatric disorders associated with fragile X in the young female. Pediatrics, 91(2), 321-329.
16. Freund, L. S., Reiss, A. L., Hagerman, R. J., & Vinogradov, S. (1992). Chromosome fragility and psychopathology in obligate female carriers of the fragile X chromosome. Archives of General Psychiatry, 49(1), 54-60.
17. Goodlin-Jones, B., Tassone, F., & Gane, L. W. (2004). Autistic spectrum disorder and the fragile X premutation. Journal of Developmental and Behavioral Pediatrics, 25(6), 392-398.
18. Hagerman, R. J. (2002). Physical and behavioral phenotype. In R. J. Hagerman, & P. J. Hagerman (Eds.), Fragile X syndrome: Diagnosis, treatment and research (3rd ed., pp. 3-109). Baltimore: The Johns Hopkins University Press.
19. Hagerman, P. J., & Hagerman R. J. (2004a). The fragile-X premutation: a maturing perspective. American Journal of Human Genetics, 74(5), 805-816.
20. Hagerman, P. J., & Hagerman, R. J. (2004b). Fragile X-associated tremor/ataxia Syndrome (FXTAS). Mental Retardation and Developmental Disabilities Research Reviews, 10(1), 25-30.
21. Hagerman, R. J., Hills, J., Scharfenaker, S., et al. (1999). Fragile X syndrome and selective mutism. American Journal of Medical Genetics, 83, 313-317.
22. Hagerman, R. J., Leavitt, B. R., Farzin, F., Jacquemont, S., Greco, C. M., Brunberg, J. A., et al. (2004). Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. American Journal of Human Genetics, 74(5), 1051-1056.
23. Hagerman, R. J., Leehey, M., Heinrichs, W., Tassone, F., Wilson, R., Hills, J., et al. (2001). Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology, 57, 127-130.
24. Hall, D. A., Berry-Kravis, E., Jacquemont, S., Rice, C. D., Cogswell, J., Zhang, L., et al. (2005). Initial diagnoses given to persons with the fragile X associated tremor/ataxia Syndrome (FXTAS). Neurology, 65, 299-301.
25. Hall, D. A., Hagerman, R. J., Hagerman, P. J., Jacquemont, S., & Leehey, M. A. (2006). Prevalence of FMR1 repeat expansions in movement disorders. A systematic review. Neuroepidemiology, 26, 151-155.
26. Hatton, D., Sideris, J., Skinner, M., Mankowski, J., Bailey, D. B., Jr., Roberts, J., et al. (2006). Autistic behavior in children with fragile X syndrome: Prevalence, stability, and the impact of FMRP. American Journal of Medical Genetics. Part A, 140(17), 1804-1813.
27. Hessl, D., Tassone, F., Loesch, D., Berry-Kravis, E., Leehey, M., Gane, L., et al. (2005). Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 139(1), 115-121.
28. Hundscheid, R. D., Braat, D. D., Kiemeney, L. A., Smits, A. P., & Thomas, C. M. (2001). Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Human Reproduction, 16(3), 457-462.
29. Jacquemont, S., Hagerman, R. J., Leehey, M., Grigsby, J., Zhang, L., Brunberg, J. A., et al. (2003). Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates. American Journal of Human Genetics, 72, 869-878.
30. Jacquemont, S., Hagerman, R. J., Leehey, M. A., Hall, D. A., Levine, R. A., Brunberg, J. A., et al. (2004). Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA, 291(4), 460-469.
31. Jacquemont, S., Leehey, M. A., Hagerman, R. J., Beckett, L. A., & Hagerman P. J. (2006). Size bias of fragile X premutation alleles in late-onset movement disorders. Journal of Medical Genetics, 43, 804-809.
32. Johnston, C., Eliez, S., Dyer-Friedman, J., Hessl, D., Glaser, B., Blasey, C., et al. (2001). Neurobehavioral phenotype in carriers of the fragile X premutation. American Journal of Medical Genetics, 103(4), 314-319.
33. Kamm, C., Healy, D. G., Quinn, N. P., Wullner, U., Moller, J. C., Schols, L., et al. (2005). The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: Data from the EMSA Study Group. Brain, 128(Pt 8), 1855-1860.
34. Kaufmann, W. E., Cortell, R., Kau, A. S., Bukelis, I., Tierney, E., Gray, R. M., et al. (2004). Autism spectrum disorder in fragile X syndrome: Communication, social interaction, and specific behaviors. American Journal of Medical Genetics, 129A(3), 225-234.
35. Lachiewicz, A. M. (1992). Abnormal behaviors of young girls with fragile X syndrome. American Journal of Medical Genetics, 43(1-2), 72-77.
36. Lachiewicz, A. (1995). Females with fragile X syndrome: A review of the effects of an abnormal gene. Mental Retardation and Developmental Disabilities Research Reviews, 1, 292-297.
37. Loesch, D. Z., Huggins, R. M., & Hagerman, R. J. (2004). Phenotypic variation and FMRP levels in fragile X. Mental Retardation and Developmental Disabilities Research Reviews, 10(1), 31-41.
38. Maddalena, A., Richards, C. S., McGinniss, M. J., Brothman, A., Desnick, R. J., Grier, R. E., et al. (2001). Technical standards and guidelines for fragile X: The first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee. Genetics in Medicine, 3(3), 200-205.
39. Mazzocco, M. M., Kates, W. R., Baumgardner, T. L., Freund, L. S., & Reiss, A.L. (1997). Autistic behaviors among girls with fragile X syndrome. Journal of Autism and Developmental Disorders, 27(4), 415-435.
40. McConkie-Rosell, A., Finucane, B. M., Cronister, A., Abrams, L., Bennett, R. L., & Pettersen, B. J. (2005). Genetic counseling for fragile X syndrome: Updated recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling, 14(4), 249-270.
41. McConkie-Rosell, A., Spiridigliozzi, G. A., Iafolla, T., Tarleton, J., & Lachiewicz, A. M. (1997). Carrier testing in the fragile X syndrome: Attitudes and opinions of obligate carriers. American Journal of Medical Genetics, 68(1), 62-69.
42. McConkie-Rosell, A., Spiridigliozzi, G. A., Sullivan, J. A., Dawson, D. V., & Lachiewicz, A. M. (2000). Carrier testing in fragile X syndrome: Effect on self-concept. American Journal of Medical Genetics, 92(5), 336-342.
43. McConkie-Rosell, A., Spiridigliozzi, G. A., Sullivan, J. A., Dawson, D. V., & Lachiewicz, A. M. (2002). Carrier testing in fragile X syndrome: When to tell and test. American Journal of Medical Genetics, 110, 36-44.
44. Morton, J. E., Bundey, S., Webb, T. P., MacDonald, F., Rindl, P. M., & Bullock, S. (1997). Fragile X syndrome is less common than previously estimated. Journal of Medical Genetics, 34(1), 1-5.
45. Murray, J., Cuckle, H., Taylor, G., & Hewison, J. (1997). Screening for fragile X syndrome: Information needs for health planners. Journal of Medical Screening, 4, 60-94.
46. Murray, A., Webb, J., MacSwiney, F., Shipley, E., Morton, N., & Conway, G. (1999). Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Human Reproduction, 14, 1217-1218.
47. Nolin, S. L., Brown, W. T., Glicksman, A., Houck, G. E., Jr., Gargano, A. D., Sullivan, A., et al. (2003). Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. American Journal of Human Genetics, 72, 454-464.
48. Reiss, A. L., & Dant, C. C. (2003). The behavioral neurogenetics of fragile X syndrome: Analyzing gene-brain-behavior relationships in child developmental psychopathologies. Development and Psychopathology, 15(4), 927-968.
49. Reiss, A. L., Freund, L., Abrams, M. T., Boehm, C., & Kazazian, H. (1993). Neurobehavioral effects of the fragile X premutation in adult women: A controlled study. American Journal of Human Genetics, 52(5), 884-894.
50. Ross, L. F. (2006). Screening for conditions that do not meet the Wilson and Jungner criteria: The case of Duchenne muscular dystrophy. American Journal of Medical Genetics A, 140(8), 914-922.
51. Rousseau, F., Rouillard, P., Morel, M. L., Khandjian, E. W., & Morgan, K. (1995). Prevalence of carriers of premutation-size alleles of the FMRI gene-And implications for the population genetics of the fragile X syndrome. American Journal of Human Genetics, 57(5), 1006-1018.
52. Sherman, S., Pletcher, B. A., & Driscoll, D. A. (2005). Fragile X syndrome: Diagnostic and carrier testing. Genetics in Medicine, 7(8), 584-587.
53. Sobesky, W. E. (1996). The treatment of emotional and behavioral problems. In R. J. Hagerman, & A. Cronister (Eds.), Fragile X syndrome: Diagnosis, treatment, and research (2nd ed., pp. 332-348). Baltimore: The Johns Hopkins University Press.
54. Sobesky, W. E., Taylor, A. K., Pennington, B. F., Bennetto, L., Porter, D., Riddle, J., et al. (1996). Molecular-clinical correlations in females with fragile X. American Journal of Medical Genetics, 64(2), 340-345.
55. Sullivan, A. K., Marcus, M., Epstein, M. P. Allen, E. G., Anido, A. E., Paquin, J. J., et al. (2005). Association of FMR1 repeat size with ovarian dysfunction. Human Reproduction, 20(2), 402-412.
56. Tassone, F., Hagerman, R. J., Gane, L. W., Taylor, A. K. (1999a). Strong similarities of the FMR1 mutation in multiple tissues: Postmortem studies of a male with the full mutation and a male carrier of a premutation. Journal of Medical Genetics, 84, 240-244.
57. Tassone, F., Hagerman, R. J., Ikle, D. N., Dyer, P. N., Lampe, M., Willemsen, R., et al. (1999b). FMRP expression as a potential prognostic indicator in fragile X syndrome. American Journal of Medical Genetics, 84(3), 250-261.
58. Tassone, F., Hagerman, R. J., Taylor, A. K., Mills, J. B., Harris, S. W., Gane, L. W., et al. (2000). Clinical involvement and protein expression in individuals with the FMR1 premutation. American Journal of Medical Genetics, 91, 144-152.
59. Turner, G., Webb, T., Wake, S., & Robinson, H. (1996). Prevalence of fragile X syndrome. American Journal of Medical Genetics, 64(1), 196-197.
60. Van Dam, D., Errijgers, V., Kooy, F., Willemsen, R., Mientjes, E., Oostra, B., et al. (2005). Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS). Behavioral Brain Research, 162(2), 233-239.
61. Van Esch, H., Dom, R., Bex, D., Salden, I., Caeckebeke, J., Wibail, A., et al. (2005). Screening for FMR-1 premutations in 122 older Flemish males presenting with ataxia. European Journal of Human Genetics, 13(1), 121-123.
62. Welt, C. K., Smith, P. C., & Taylor, A. E. (2004). Evidence of early ovarian aging in fragile X premutation carriers. Journal of Clinical Endocrinology and Metabolism, 89(9), 4569-4574.
63. Wittenberger, M. D., Hagerman, R. J., Sherman, S. L., McConkie-Rosell, A, Welt, C. K., Rebar, R. W., et al. (2007). The FMR1 premutation and reproduction. Fertility and Sterility, 87(3), 456-465.
64. Zuhlke, C., Budnik, A., Gehlken, U., Dalski, A., Purmann, S., Naumann, M., et al. (2004). FMR1 premutation as a rare cause of late onset ataxia-Evidence for FXTAS in female carriers. Journal de Neurologie, 251(11), 1418-1419.